Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

431 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center.
Nicolatou-Galitis O, Papadopoulou E, Sarri T, Boziari P, Karayianni A, Kyrtsonis MC, Repousis P, Barbounis V, Migliorati CA. Nicolatou-Galitis O, et al. Among authors: papadopoulou e. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Aug;112(2):195-202. doi: 10.1016/j.tripleo.2011.02.037. Epub 2011 May 31. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011. PMID: 21622014
Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.
Nicolatou-Galitis O, Kouri M, Papadopoulou E, Vardas E, Galiti D, Epstein JB, Elad S, Campisi G, Tsoukalas N, Bektas-Kayhan K, Tan W, Body JJ, Migliorati C, Lalla RV; MASCC Bone Study Group. Nicolatou-Galitis O, et al. Among authors: papadopoulou e. Support Care Cancer. 2019 Feb;27(2):383-394. doi: 10.1007/s00520-018-4501-x. Epub 2018 Oct 23. Support Care Cancer. 2019. PMID: 30353228
The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumab.
Papadopoulou E, Nicolatou-Galitis O, Papassotiriou I, Linardou H, Karagianni A, Tsixlakis K, Tarampikou A, Michalakakou K, Vardas E, Bafaloukos D. Papadopoulou E, et al. Support Care Cancer. 2020 Jan;28(1):177-184. doi: 10.1007/s00520-019-04793-2. Epub 2019 Apr 17. Support Care Cancer. 2020. PMID: 31001696
Alveolar bone histological necrosis observed prior to extractions in patients, who received bone-targeting agents.
Nicolatou-Galitis O, Papadopoulou E, Vardas E, Kouri M, Galiti D, Galitis E, Alexiou KE, Tsiklakis K, Ardavanis A, Razis E, Athanasiadis I, Droufakou S, Psyrri A, Karamouzis MV, Linardou H, Daliani D, Tzanninis D, Sachanas S, Laschos K, Kyrtsonis MC, Antoniou F, Laskarakis A, Giassas S, Nikolaidi A, Rigakos G, Ntokou A, Migliorati CA, Ripamonti CI. Nicolatou-Galitis O, et al. Among authors: papadopoulou e. Oral Dis. 2020 Jul;26(5):955-966. doi: 10.1111/odi.13294. Epub 2020 Mar 3. Oral Dis. 2020. PMID: 32011077
Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi study.
Abdalla-Aslan R, Bonomo P, Keefe D, Blijlevens N, Cao K, Cheung YT, Fregnani ER, Miller R, Raber-Durlacher J, Epstein J, Van Sebille Y, Kauark-Fontes E, Kandwal A, McCurdy-Franks E, Finkelstein J, McCarvell V, Zadik Y, Ottaviani G, Amaral Mendes R, Speksnijder CM, Wardill HR, Bossi P; MASCC Mucositis Study Group. Abdalla-Aslan R, et al. EClinicalMedicine. 2024 Jun 6;73:102675. doi: 10.1016/j.eclinm.2024.102675. eCollection 2024 Jul. EClinicalMedicine. 2024. PMID: 38933098 Free PMC article.
431 results